Dynex Capital, Inc. (DX) Stock Price & How to Invest

Dynex Capital, Inc. is a Virginia-based real estate investment trust that invests primarily in agency mortgage-backed securities (MBS) guaranteed by Fannie Mae, Freddie Mac and Ginnie Mae, along with related hedges. It borrows heavily in the repurchase (repo) market to buy these securities, earning the spread between the yield on its mortgage assets and its short-term funding costs, and it returns most of that income to shareholders as a monthly dividend. As of mid-2026 the company managed an MBS and TBA portfolio of roughly $24.8 billion against about $2.8 billion of equity, running adjusted leverage near 8.6x.

The investment picture is dominated by rates and spreads rather than by any operating business. When mortgage spreads tighten and funding costs fall, book value and economic returns rise; when spreads widen, book value can drop sharply, as it did in the first quarter of 2026 when the company posted an $83 million net loss to common shareholders and book value fell to about $12.60 per share. The shares are prized for a headline dividend yield in the mid-teens, but that yield comes with the leverage, hedging complexity and interest-rate sensitivity typical of the agency mortgage REIT model.

Book value is highly sensitive to interest rates and mortgage-spread moves, and a widening in spreads produced a negative 2.5% economic return and an $83 million net loss to common shareholders in Q1 2026. High leverage near 8.6x magnifies both gains and losses on the portfolio. The dividend is not guaranteed and can be cut if spread income or book value deteriorates, as has happened across the agency mortgage REIT sector historically. Frequent equity issuance can dilute existing shareholders, and rising short-term funding costs would compress the net interest margin. As a leveraged, rate-driven vehicle, DX can lose value even when its underlying agency securities carry no credit risk.

5 analysts publish price targets on DX, averaging $14.75 against a $12.71 price as of August 2026, or +16.1%. The published targets run from $14.50 to $15.00, a narrow spread, and the ratings split 4 buy, 2 hold, 0 sell. Over the last six months there has been 1 raise and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full DX forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Dynex Capital, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Falling-rate and steepening-curve tailwind. Dynex's net interest income rose to about $79 million in Q1 2026 as declining short-term financing costs widened the spread on its agency MBS. The most optimistic published target, $15.00, assumes this works close to its best case.

The case against. Book value is highly sensitive to interest rates and mortgage-spread moves, and a widening in spreads produced a negative 2.5% economic return and an $83 million net loss to common shareholders in Q1 2026. The most pessimistic target, $14.50, is roughly what DX is worth if this bites instead.

Read the full bull and bear case on DX, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Dynex Capital, Inc.'s investor relations page or your broker.

• Market cap: ~$2.8B
• Revenue (TTM): ~$304M
• Net income (TTM): ~$231M
• Book value / share (Q1 2026): ~$12.60
• Dividend (annualized): ~$2.04 (~15% yield)
• Adjusted leverage: ~8.6x

DX trades close to, and at times modestly above, its stated book value per share, which is typical for an agency mortgage REIT when the market expects spreads to earn attractive returns. Because REIT payout rules push most taxable income out as dividends, the eye-catching mid-teens yield reflects leverage and rate risk rather than a bargain valuation. Book value moved meaningfully quarter to quarter in 2026, so point-in-time price-to-book can shift quickly.

Other names that sit close to DX: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get DX exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so DX sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where DX fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

DX is a leveraged bet on agency mortgage spreads dressed as a monthly dividend payer, rewarding income seekers who can stomach real book-value volatility.

Whether DX is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is DX a buy or a sell?, and where the stock could go from here in the DX stock forecast.

For income investors, whether DX pays a dividend and how the payout looks is covered in does DX pay a dividend? And to weigh DX against a peer, read the full side-by-side comparisons: DX vs AGNC and DX vs NLY.